share_log
Reuters ·  Apr 24 04:05
Candel Therapeutics Announces Oral Presentation of Positive Phase 3 Can-2409 Results in Localized Prostate Cancer at Asco 2025
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment